| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.02 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.02 |